Search by Drug Name or NDC
NDC 00310-6627-02 SymlinPen 1000 ug/mL Details
SymlinPen 1000 ug/mL
SymlinPen is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is PRAMLINTIDE ACETATE.
MedlinePlus Drug Summary
Pramlintide is used with mealtime insulin to control blood sugar levels in people who have diabetes. Pramlintide is only used to treat patients whose blood sugar could not be controlled by insulin or insulin and an oral medication for diabetes. Pramlintide is in a class of medications called antihyperglycemics. It works by slowing the movement of food through the stomach. This prevents blood sugar from rising too high after a meal, and may decrease appetite and cause weight loss. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 00310-6627-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pramlintide Injection
Product Information
NDC | 00310-6627 |
---|---|
Product ID | 0310-6627_d75a39a9-b344-4e60-9d6f-c72df2c8e91d |
Associated GPIs | 2715005010D240 |
GCN Sequence Number | 063735 |
GCN Sequence Number Description | pramlintide acetate PEN INJCTR 2700/2.7ML SUBCUT |
HIC3 | C4H |
HIC3 Description | ANTIHYPERGLYCEMIC, AMYLIN ANALOG-TYPE |
GCN | 99450 |
HICL Sequence Number | 032805 |
HICL Sequence Number Description | PRAMLINTIDE ACETATE |
Brand/Generic | Brand |
Proprietary Name | SymlinPen |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | pramlintide acetate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 1000 |
Active Ingredient Units | ug/mL |
Substance Name | PRAMLINTIDE ACETATE |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Pharmaceutical Class | Amylin Agonists [MoA], Amylin Analog [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021332 |
Listing Certified Through | 2023-12-31 |
Package
NDC 00310-6627-02 (00310662702)
NDC Package Code | 0310-6627-02 |
---|---|
Billing NDC | 00310662702 |
Package | 2 CARTRIDGE in 1 CARTON (0310-6627-02) / 2.7 mL in 1 CARTRIDGE |
Marketing Start Date | 2015-01-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |